All questionsSafety: Rexulti (brexpiprazole), all indications17 questions · 1 sourceSafetyIs Rexulti a controlled substance?“REXULTI contains brexpiprazole, which is not a controlled substance.” (opens the source at this quote in a new tab)CopyFlag“Animals given access to REXULTI did not self-administer the drug, suggesting that REXULTI does not have rewarding properties.” (opens the source at this quote in a new tab)CopyFlagDoes Rexulti prolong the QT interval?“At a dose 3 times the MRHD for the treatment of schizophrenia and 4 times the MRHD for adjunctive therapy to antidepressants for the treatment of MDD or agitation associated with dementia due to Alzheimer’s disease, REXULTI does not prolong the QTc interval to any clinically relevant extent.” (opens the source at this quote in a new tab)CopyFlagDoes stopping Rexulti cause withdrawal symptoms?“Humans and animals that received chronic REXULTI administration did not demonstrate any withdrawal signs upon drug discontinuation. This suggests that REXULTI does not produce physical dependence.” (opens the source at this quote in a new tab)CopyFlagWhat should be done after a Rexulti overdose?“There is limited clinical trial experience regarding human overdosage with REXULTI. Management of a REXULTI overdose should concentrate on supportive therapy, maintaining an adequate airway, oxygenation and ventilation, and management of symptoms. Close medical supervision and monitoring should continue until the patient recovers.” (opens the source at this quote in a new tab)CopyFlag“Consider contacting the Poison Help Line (1-800-222-1222) or a medical toxicologist for additional overdosage management recommendations. Oral activated charcoal and sorbitol (50 g/240 mL), administered one hour after ingesting oral REXULTI, decreased brexpiprazole Cmax and area under the curve (AUC) by approximately 5% to 23% and 31% to 39% respectively; however, there is insufficient information available on the therapeutic potential of activated charcoal in treating an overdose with REXULTI. There is no information on the effect of hemodialysis in treating an overdose with REXULTI; hemodialysis is unlikely to be useful because brexpiprazole is highly bound to plasma proteins.” (opens the source at this quote in a new tab)CopyFlagWarningsWhat is the Rexulti boxed warning for suicidal thoughts and dementia-related psychosis?“WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. REXULTI is not approved for the treatment of patients with dementia-related psychosis without agitation associated with dementia due to Alzheimer’s disease [see Warnings and Precautions (5.1)]. Suicidal Thoughts and Behaviors Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric patients and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors [see Warnings and Precautions (5.2)]. The safety and effectiveness of REXULTI have not been established in pediatric patients with MDD [see Warnings and Precautions (5.2), Use in Specific Populations (8.4)].” (opens the source at this quote in a new tab)CopyFlagCan Rexulti raise blood sugar or cause diabetes?“Hyperglycemia and diabetes mellitus, in some cases extreme and associated with diabetic ketoacidosis hyperosmolar coma or death, have been reported in patients treated with atypical antipsychotics. There have been reports of hyperglycemia in patients treated with REXULTI. Assess fasting plasma glucose before or soon after initiation of antipsychotic medication and monitor periodically during long-term treatment.” (opens the source at this quote in a new tab)CopyFlag“In the 6-week placebo-controlled, fixed-dose clinical studies in adult patients with MDD, the proportions of patients with shifts in fasting glucose from normal (<100 mg/dL) to high (≥126 mg/dL) and borderline (≥100 and <126 mg/dL) to high were similar in patients treated with REXULTI and placebo.” (opens the source at this quote in a new tab)CopyFlagDoes Rexulti raise cholesterol or triglycerides?“Atypical antipsychotics cause adverse alterations in lipids. Before or soon after initiation of antipsychotic medication, obtain a fasting lipid profile at baseline and monitor periodically during treatment.” (opens the source at this quote in a new tab)CopyFlag“In the 6-week placebo-controlled, fixed-dose clinical studies in adult patients with MDD, changes in fasting total cholesterol, LDL cholesterol, and HDL cholesterol were similar in REXULTI- and placebo-treated patients. Table 3 shows the proportions of patients with changes in fasting triglycerides. Table 3 Change in Fasting Triglycerides in the 6-Week Placebo-Controlled, Fixed-Dose MDD Studies Proportion of Patients with Shifts Baseline to Post-Baseline Triglycerides Placebo 1 mg/day 2 mg/day 3 mg/day Normal to High (<150 mg/dL to ≥200 and <500 mg/dL) 6% (15/257)* 5% (7/145)* 13% (15/115)* 9% (13/150)* Normal/Borderline to Very High (<200 mg/dL to ≥500 mg/dL) 0% (0/309)* 0% (0/177)* 0.7% (1/143)* 0% (0/179)* *denotes n/N where N=the total number of patients who had a measurement at baseline and at least one post-baseline result; n=the number of patients with shift” (opens the source at this quote in a new tab)CopyFlagNote: Table 3 columns are placebo, REXULTI 1 mg/day, 2 mg/day, and 3 mg/day, in that order.Can Rexulti cause tardive dyskinesia?“Tardive dyskinesia, a syndrome consisting of potentially irreversible, involuntary, dyskinetic movements, may develop in patients treated with antipsychotic drugs. The risk appears to be highest among the elderly, especially elderly women, but it is impossible to predict which patients will develop the syndrome. Whether antipsychotic drugs differ in their potential to cause tardive dyskinesia is unknown. The risk of tardive dyskinesia and the likelihood that it will become irreversible appear to increase as the duration of treatment and the cumulative dose increases. The syndrome can develop after relatively brief treatment periods, at low doses. It may also occur after discontinuation of treatment.” (opens the source at this quote in a new tab)CopyFlag“If signs and symptoms of tardive dyskinesia appear in a patient treated with REXULTI, drug discontinuation should be considered. However, some patients may require treatment with REXULTI despite the presence of the syndrome.” (opens the source at this quote in a new tab)CopyFlagCan Rexulti cause neuroleptic malignant syndrome (NMS)?“Neuroleptic Malignant Syndrome (NMS), a potentially fatal symptom complex, has been reported in association with administration of antipsychotic drugs, including REXULTI.” (opens the source at this quote in a new tab)CopyFlag“Clinical manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental status, and evidence of autonomic instability (irregular pulse or blood pressure, tachycardia, diaphoresis and cardiac dysrhythmia). Additional signs may include elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis), and acute renal failure. If NMS is suspected, immediately discontinue REXULTI and provide intensive symptomatic treatment and monitoring.” (opens the source at this quote in a new tab)CopyFlagCan Rexulti cause compulsive gambling or other urges?“Post-marketing case reports suggest that patients can experience intense urges, particularly for gambling, and the inability to control these urges while taking REXULTI. Other compulsive urges, reported less frequently, include sexual urges, shopping, eating, or binge eating, and other impulsive or compulsive behaviors. Because patients may not recognize these behaviors as abnormal, it is important for prescribers to ask patients or their caregivers specifically about the development of new or intense gambling urges, compulsive sexual urges, compulsive shopping, binge or compulsive eating, or other urges while being treated with REXULTI. In some cases, although not all, urges were reported to have stopped when the dose was reduced, or the medication was discontinued. Compulsive behaviors may result in harm to the patient and others if not recognized. Consider dose reduction or stopping the medication if a patient develops such urges.” (opens the source at this quote in a new tab)CopyFlagCan Rexulti lower white blood cell counts?“Leukopenia and neutropenia have been reported during treatment with antipsychotic agents. Agranulocytosis (including fatal cases) has been reported with other agents in this class. Possible risk factors for leukopenia and neutropenia include pre-existing low white blood cell count (WBC) or absolute neutrophil count (ANC) and history of drug-induced leukopenia or neutropenia. In patients with a pre- existing low WBC or ANC or a history of drug-induced leukopenia or neutropenia, perform a complete blood count (CBC) frequently during the first few months of therapy. In such patients, consider discontinuation of REXULTI at the first sign of a clinically significant decline in WBC in the absence of other causative factors. Monitor patients with clinically significant neutropenia for fever or other symptoms or signs of infection and treat promptly if such symptoms or signs occur. Discontinue REXULTI in patients with absolute neutrophil count <1000/mm3 and follow their WBC until recovery.” (opens the source at this quote in a new tab)CopyFlagDoes Rexulti increase the risk of falls?“Antipsychotics, including REXULTI, may cause somnolence, postural hypotension, motor, and sensory instability, which may lead to falls and, consequently, fractures or other injuries. For patients with diseases, conditions, or medications that could exacerbate these effects, complete fall risk assessments when initiating antipsychotic treatment and recurrently for patients on long-term antipsychotic treatment.” (opens the source at this quote in a new tab)CopyFlagDoes Rexulti increase stroke risk in older adults with dementia?“In placebo-controlled trials in elderly patients with dementia, patients randomized to risperidone, aripiprazole, and olanzapine had a higher incidence of stroke and transient ischemic attack, including fatal stroke. REXULTI is not approved for the treatment of patients with dementia-related psychosis without agitation associated with dementia due to Alzheimer’s disease [see Boxed Warning, Warnings and Precautions (5.1)].” (opens the source at this quote in a new tab)CopyFlagCan Rexulti cause seizures?“Like other antipsychotic drugs, REXULTI may cause seizures. This risk is greatest in patients with a history of seizures or with conditions that lower the seizure threshold. Conditions that lower the seizure threshold may be more prevalent in older patients.” (opens the source at this quote in a new tab)CopyFlagCan Rexulti affect body temperature regulation?“Atypical antipsychotics may disrupt the body’s ability to reduce core body temperature. Strenuous exercise, exposure to extreme heat, dehydration, and anticholinergic medications may contribute to an elevation in core body temperature; use REXULTI with caution in patients who may experience these conditions.” (opens the source at this quote in a new tab)CopyFlag“Counsel patients regarding appropriate care in avoiding overheating and dehydration [see Warnings and Precautions (5.12)].” (opens the source at this quote in a new tab)CopyFlagCan Rexulti cause trouble swallowing?“Esophageal dysmotility and aspiration have been associated with antipsychotic drug use. Antipsychotic drugs, including REXULTI, should be used cautiously in patients at risk for aspiration.” (opens the source at this quote in a new tab)CopyFlagWho should not take Rexulti (contraindications)?“REXULTI is contraindicated in patients with a known hypersensitivity to brexpiprazole or any of its components. Reactions have included rash, facial swelling, urticaria, and anaphylaxis.” (opens the source at this quote in a new tab)CopyFlag